Initial data from the COVID-19 Global Rheumatology Alliance provider registries - Authors' reply.
作者信息
Gianfrancesco Milena A
出版信息
Lancet Rheumatol. 2020 Jun;2(6):e317. doi: 10.1016/S2665-9913(20)30125-9. Epub 2020 May 5.
Abstract
摘要
相似文献
1
Initial data from the COVID-19 Global Rheumatology Alliance provider registries - Authors' reply.来自COVID-19全球风湿病联盟提供者登记处的初始数据——作者回复。
Lancet Rheumatol. 2020 Jun;2(6):e317. doi: 10.1016/S2665-9913(20)30125-9. Epub 2020 May 5.
2
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.风湿性疾病与2019冠状病毒病：来自2019冠状病毒病全球风湿病联盟医疗服务提供者登记处的初步数据。
Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3. Epub 2020 Apr 16.
3
Initial data from the COVID-19 Global Rheumatology Alliance provider registries.来自新冠全球风湿病联盟提供者登记处的初始数据。
Lancet Rheumatol. 2020 Jun;2(6):e317. doi: 10.1016/S2665-9913(20)30124-7. Epub 2020 May 5.
4
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance Registry.抗击新冠疫情需要您的帮助：请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2020 Dec;23(12):1744. doi: 10.1111/1756-185X.14038.
5
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).意大利风湿病学 COVID-19 ：意大利风湿病学会（CONTROL-19）意大利登记处的初步结果。
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):748-753. Epub 2020 Jul 28.
6
The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.风湿病学界对COVID-19大流行的应对：COVID-19全球风湿病联盟的成立。
Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191.
7
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance Registry.抗击新冠疫情需要您的帮助：请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2020 Nov;23(11):1606. doi: 10.1111/1756-185X.14026.
8
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance Registry.抗击新冠疫情需要您的帮助：请为新冠全球风湿病联盟注册库做出贡献。
Int J Rheum Dis. 2020 Sep;23(9):1262. doi: 10.1111/1756-185X.13967.
9
Authors' reply.作者回复。
Scand J Rheumatol. 2020 Mar;49(2):171-172. doi: 10.1080/03009742.2019.1701074.
10
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.抗击新冠疫情需要您的帮助：请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2021 Jul;24(7):973. doi: 10.1111/1756-185X.14118.
引用本文的文献
1
Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.2019年冠状病毒病大流行期间特发性炎性肌病的临床病程：单中心经验
Future Virol. 2022 May. doi: 10.2217/fvl-2021-0146. Epub 2022 Jun 15.
2
Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation.2019 年冠状病毒病（COVID-19）合并系统性自身免疫性疾病或血管炎患者的影像学表现。
J Thromb Thrombolysis. 2021 Feb;51(2):339-348. doi: 10.1007/s11239-020-02289-z. Epub 2020 Sep 26.
本文引用的文献
1
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
2
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.风湿性疾病与2019冠状病毒病：来自2019冠状病毒病全球风湿病联盟医疗服务提供者登记处的初步数据。
Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3. Epub 2020 Apr 16.
3
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新冠肺炎患者：一则评论
Ann Rheum Dis. 2020 Jun;79(6):e61. doi: 10.1136/annrheumdis-2020-217506. Epub 2020 Apr 15.
Zotero 插件